Ruoxi Zhang | Cardiology | Best Researcher Award

Posted on by Pencis

Dr. Ruoxi Zhang | Cardiology | Best Researcher Award

Dr. Ruoxi Zhang, Harbin Medical University, China.

Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. He earned his doctorate from Harbin Medical University and has over a decade of clinical experience at renowned institutions, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to advancing medical research. His extensive publications focus on artificial intelligence in cardiology, interventional techniques, and diagnostic innovations. Dr. Zhang’s dedication to medical science and patient care underscores his significant contributions to the field of cardiovascular research.

Author Profile

Suitability for Best Researcher Award

Dr. Ruoxi Zhang is a highly accomplished physician and researcher in cardiovascular medicine, with over a decade of experience in clinical practice and academic research. He holds a Doctorate in Clinical Medicine from Harbin Medical University and has served in prestigious hospitals, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital at Shanghai Jiao Tong University School of Medicine.

Education:

Dr. Ruoxi Zhang has a strong academic foundation in clinical and internal medicine. He earned his Doctorate in Clinical Medicine from Harbin Medical University (2013–2016) and a Master’s degree in Internal Medicine from the same institution (2007–2010). His medical journey began with a Bachelor’s degree in Clinical Medicine from Qiqihar Medical University (2002–2007). His advanced education equipped him with extensive knowledge in diagnosing and treating complex medical conditions. Through rigorous academic training and research, Dr. Zhang has developed a deep expertise in cardiovascular medicine, laying the groundwork for his distinguished career as a physician and researcher in the medical field.

Professional Experience:

Dr. Ruoxi Zhang has over a decade of experience in clinical medicine, specializing in cardiology. He began his medical career as a physician at The Second Affiliated Hospital of Harbin Medical University, where he served for ten years, gaining expertise in patient care and advanced medical procedures. He then joined Harbin Yinghua Hospital, further refining his skills in cardiovascular treatment. Currently, he is a physician at Suzhou Kowloon Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. His extensive clinical experience, combined with his research contributions, underscores his commitment to advancing cardiovascular medicine and improving patient outcomes.

Research Interests:

Dr. Ruoxi Zhang’s research interests focus on cardiovascular medicine, interventional cardiology, and advanced imaging techniques for diagnosing and treating heart diseases. He is particularly engaged in artificial intelligence applications in intracardiac echocardiography and computed tomography-derived fractional flow reserve to enhance diagnostic precision. His work explores innovative interventional strategies for patients with acute coronary syndromes, myocardial infarction, and diabetes-related cardiovascular conditions. Additionally, he investigates endothelialization processes, stent implantation techniques, and platelet aggregation in post-percutaneous coronary intervention patients. Dr. Zhang is committed to integrating novel technologies into clinical practice to improve cardiovascular outcomes and patient care.

Recognition and Impact:

Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to the advancement of medical research. With numerous high-impact publications in esteemed journals, his work on artificial intelligence in echocardiography and interventional cardiology has influenced clinical practices. His research has enhanced diagnostic precision and treatment efficacy, earning recognition from the medical community. Through his dedication to innovation and patient-centered care, Dr. Zhang has established himself as a leading expert, significantly impacting the field of cardiovascular research.

Citations:

Citations – 576
h-index – 14
i10-index – 19

Conclusion:

Dr. Ruoxi Zhang’s strong academic background, extensive professional experience, editorial roles, and prolific research contributions make him a highly suitable candidate for the Best Researcher Award. His work has significantly impacted cardiovascular medicine, and his dedication to advancing medical research sets him apart as an outstanding scholar and clinician.

 Top Notable Publications

Colchicine alleviates cholesterol crystal‐induced endothelial cell pyroptosis through activating AMPK/SIRT1 pathway

Author(s): M Yang, H Lv, Q Liu, L Zhang, R Zhang, X Huang, X Wang, B Han, S Hou, …

Journal: Oxidative Medicine and Cellular Longevity

Year: 2020 📅

Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow

Author(s): D Liu, H Lv, Q Liu, Y Sun, S Hou, L Zhang, M Yang, B Han, G Wang, …

Journal: Journal of Translational Medicine

Year: 2019 📰

C1q/TNF‐related protein 9 inhibits the cholesterol‐induced vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP‐dependent kinase

Author(s): Q Liu, H Zhang, J Lin, R Zhang, S Chen, W Liu, M Sun, W Du, J Hou, B Yu

Journal: Journal of Cellular and Molecular Medicine

Year: 2017 🧬

C1q/Tumor necrosis factor-related protein-3 protects macrophages against LPS-induced lipid accumulation, inflammation and phenotype transition via PPARγ and TLR4-mediated pathways

Author(s): J Lin, Q Liu, H Zhang, X Huang, R Zhang, S Chen, X Wang, B Yu, J Hou

Journal: Oncotarget

Year: 2017 💡

Identification of biomarkers for unstable angina by plasma metabolomic profiling

Author(s): M Sun, X Gao, D Zhang, C Ke, Y Hou, L Fan, R Zhang, H Liu, K Li, B Yu

Journal: Molecular BioSystems

Year: 2013 🔬

Effect of clopidogrel vs ticagrelor on platelet aggregation and inflammation markers after percutaneous coronary intervention for ST-elevation myocardial infarction

Author(s): Z Jiang, R Zhang, M Sun, Q Liu, S Wang, W Wang, Q Zhao, H Zhang, …

Journal: Canadian Journal of Cardiology

Year: 2018 💓

Relationship between fragmented QRS and NT-proBNP in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention

Author(s): Q Zhao, R Zhang, J Hou, B Yu

Journal: Acta Cardiologica Sinica

Year: 2018 ❤️

C1q/TNF-related protein 9 attenuates atherosclerosis by inhibiting hyperglycemia-induced endothelial cell senescence through the AMPKα/KLF4 signaling pathway

Author(s): G Wang, B Han, R Zhang, Q Liu, X Wang, X Huang, D Liu, W Qiao, …

Journal: Frontiers in Pharmacology

Year: 2021 💪

Biomarkers investigation for in-hospital death in patients with Stanford type A acute aortic dissection

Author(s): R Zhang, S Chen, H Zhang, W Wang, J Xing, Y Wang, B Yu, J Hou

Journal: International Heart Journal

Year: 2016 ❤️

Effects of methotrexate in a rabbit model of in-stent neoatherosclerosis: an optical coherence tomography study

Author(s): R Zhang, S Chen, H Zhang, Q Liu, J Xing, Q Zhao, Y Wang, B Yu, J Hou

Journal: Scientific Reports

Year: 2016 🐇

Recombinant human thioredoxin-1 protects macrophages from oxidized low-density lipoprotein-induced foam cell formation and cell apoptosis

Author(s): H Zhang, Q Liu, JL Lin, Y Wang, RX Zhang, JB Hou, B Yu

Journal: Biomolecules & Therapeutics

Year: 2018 💉

Fragmented QRS complex is a prognostic marker of microvascular reperfusion and changes in LV function occur in patients with ST elevation myocardial infarction who underwent …

Author(s): R Zhang, S Chen, Q Zhao, M Sun, B Yu, J Hou

Journal: Experimental and Therapeutic Medicine

Year: 2017 🏥

Interleukin-35 promotes early endothelialization after stent implantation by regulating macrophage activation

Author(s): X Liu, R Zhang, J Hou, J Wu, M Zhang, S Fang, X Wang, X Huang, J Tian, …

Journal: Clinical Science

Year: 2019 💉

Correlation of serum uric acid levels with nonculprit plaque instability in patients with acute coronary syndromes: a 3‐vessel optical coherence tomography study

Author(s): D Zhang, R Zhang, N Wang, L Lin, B Yu

Journal: BioMed Research International

Year: 2018 🧪

Adipose tissue-derived autotaxin causes cardiomyopathy in obese mice

Author(s): Y Xu, Y Wang, J Liu, W Cao, L Li, H Du, E Zhan, R Zhang, H Liu, M Xu, …

Journal: Journal of Molecular Endocrinology

Year: 2019 🐁

Fulin Liu | Cardiology | Best Researcher Award

Posted on by Pencis

Prof. Fulin Liu | Cardiology | Best Researcher Award

Prof. Fulin Liu, Affiliated Hospital of Hebei University , China

Prof. Fulin Liu is a distinguished researcher and cardiac surgeon affiliated with the Affiliated Hospital of Hebei University, where he has worked since 1988. He holds a degree from Hebei Medical University and has made significant contributions to cardiovascular health, particularly in myocardial ischemia-reperfusion injury and the therapeutic effects of hydrogen-rich water. Liu has authored numerous high-impact journal articles, with recent work focusing on mitochondrial function, glioma research, and innovative healthcare solutions. His research is widely recognized in leading medical journals, underscoring his global impact and ongoing commitment to advancing medical science and patient care.

Author Profile:

🎓 Education:

Prof. Fulin Liu completed his undergraduate education at Hebei Medical University in Shijiazhuang City, Hebei, China. He attended the university from September 1983 to June 1988, where he received a medical degree, which laid the foundation for his career in cardiac surgery and medical research. This academic background has been pivotal in shaping his research focus, particularly in the fields of cardiovascular health, ischemia-reperfusion injury, and the application of hydrogen-rich water in medical treatments. Liu’s educational experiences at Hebei Medical University have significantly influenced his innovative contributions to healthcare and medical science.

💼 Professional Experience:

Prof. Fulin Liu has extensive professional experience in both clinical and research settings. Since 1988, he has been a cardiac surgeon at the Affiliated Hospital of Hebei University, where he has developed expertise in treating cardiovascular conditions, particularly myocardial ischemia-reperfusion injury. In addition to his clinical role, Liu has made significant contributions to medical research, publishing numerous articles on topics such as hydrogen-rich water, mitochondrial function, and glioma. His work bridges the gap between clinical practice and scientific discovery, advancing both patient care and medical knowledge. Liu’s career reflects a dedicated commitment to improving cardiovascular health and innovative therapies.

🌍Research Contributions:

Prof. Fulin Liu’s research contributions focus primarily on cardiovascular health, particularly myocardial ischemia-reperfusion injury and the protective effects of hydrogen-rich water. His studies have revealed critical insights into mitochondrial function and its role in heart disease, with a focus on improving therapeutic strategies. Liu has also made notable contributions to the understanding of gliomas, including the role of circular RNAs and N6-methyladenosine modifications in tumor progression. His work extends to advanced healthcare technologies, such as knowledge graphs and mobile computing in medical applications. Through his numerous published articles, Liu continues to drive innovative research with significant clinical and therapeutic implications.

🥇Award and Honors:

Prof. Fulin Liu has received numerous awards and honors throughout his distinguished career, recognizing his contributions to the field of cardiac surgery and medical research. His groundbreaking work on myocardial ischemia-reperfusion injury, hydrogen-rich water’s therapeutic effects, and his studies on gliomas have earned him widespread acclaim in the scientific community. Liu’s research has been published in top-tier medical journals, and his expertise has garnered international recognition. His dedication to advancing both clinical practices and scientific understanding has established him as a leader in his field, earning him significant accolades and reinforcing his reputation as a pioneering researcher.

Conclusion:

Prof. Fulin Liu’s extensive research and clinical expertise have made him a prominent figure in the field of cardiac surgery and biomedical research. His work on myocardial ischemia-reperfusion injury, hydrogen-rich water, and its therapeutic potential highlights his commitment to advancing cardiovascular medicine. Liu’s contributions to the understanding of molecular mechanisms in diseases like glioma further underscore his multidisciplinary approach to health research. With a remarkable publication record and ongoing involvement in clinical practice, Liu’s impact on both academic and medical communities is profound, establishing him as a leading figure in his field.

📚Publication Top Notes:

Hydrogen Protects Mitochondrial Function by Increasing the Expression of PGC-1α and Ameliorating Myocardial Ischaemia–Reperfusion Injury
Journal of Cellular and Molecular Medicine, 2024
📖 Citations: 0
[DOI: 10.1111/jcmm.70236]

Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy
Pharmacological Research, 2022
🧠 Citations: 15
[DOI: 10.1016/j.phrs.2022.106482]

Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma
Journal of Cellular and Molecular Medicine, 2021
🔬 Citations: 8
[DOI: 10.1111/jcmm.16750]

Multitask Healthcare Management Recommendation System Leveraging Knowledge Graph
Journal of Healthcare Engineering, 2021
💡 Citations: 19
[DOI: 10.1155/2021/1233483]

Medical Knowledge Graph in Chinese Using Deep Semantic Mobile Computation Based on IoT and WoT
Wireless Communications and Mobile Computing, 2021
🌐 Citations: 6
[DOI: 10.1155/2021/5590754]

M6A modification in RNA: Biogenesis, functions and roles in gliomas
Journal of Experimental and Clinical Cancer Research, 2020
🧬 Citations: 117
[DOI: 10.1186/s13046-020-01706-8]

Metabolomics Analysis of the Effect of Hydrogen-Rich Water on Myocardial Ischemia-Reperfusion Injury in Rats
Journal of Bioenergetics and Biomembranes, 2020
💧 Citations: 6
[DOI: 10.1007/s10863-020-09835-7]

Advances in circular RNAs and their role in glioma (Review)
International Journal of Oncology, 2020
🔄 Citations: 26
[DOI: 10.3892/ijo.2020.5049]

New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Biomedicine and Pharmacotherapy, 2020
🦠 Citations: 222
[DOI: 10.1016/j.biopha.2020.110195]

Pressurizing and Stretching Experiment in Arterialized Veins of Rabbits
Yiyong Shengwu Lixue/Journal of Medical Biomechanics, 2020
🐇 Citations: Not available
[DOI: 10.3969/j.issn.1005-8936.2020.02.006]

Stephane Manzo-Silberman | Cardiology | Best Researcher Award

Posted on by Pencis

Dr.Stephane Manzo-Silberman | Cardiology | Best Researcher Award 

 Dr. Stephane Manzo-Silberman, APHP Sorbonne University, France

Dr. Stephane Manzo-Silberman is a renowned cardiologist at Assistance Publique-Hôpitaux de Paris (APHP) and a faculty member at Sorbonne University, France. She specializes in cardiovascular diseases, with a focus on coronary artery disease and interventions. Dr. Manzo-Silberman is actively involved in clinical research, particularly in the fields of interventional cardiology and thrombosis, and she has contributed extensively to academic publications in these areas. In addition to her clinical work, she plays a key role in advancing medical education and promoting innovative cardiovascular therapies.

Profile:

Scopus Profile 

 

Education Qualification:

Dr. Stéphane Manzo-Silberman, MD, MSc, completed her medical and clinical training in cardiology at René Descartes University, Paris, where she earned her Doctorate in Medical Sciences (2005) and specialized in cardiology. She also holds a Master’s degree in Biological Sciences (2004). Her clinical expertise was further developed during her residency in internal medicine and cardiology (2000-2005), followed by advanced training as a senior resident in interventional cardiology at Cochin Hospital (2006-2011) and in coronary angiography and angioplasty at Clinique Pasteur, Toulouse (2006), under the mentorship of Pr. J Marco and Dr. J Fajadet.

Current Position:

Dr. Stéphane Manzo-Silberman currently serves as Senior Consultant at the Cardiac Catheterization Laboratory and Coronary Care Unit of the Cardiology Institute at Pitié-Salpêtrière Hospital, APHP, Sorbonne University, Paris. In this role, she specializes in interventional cardiology, managing complex cardiac procedures and providing advanced care for patients with coronary artery disease. Her position reflects her expertise in cardiovascular interventions and her dedication to improving clinical outcomes in cardiology.

Awards:

Dr. Stéphane Manzo-Silberman has received several prestigious awards throughout her career, including the French Society of Cardiology Prize for the best doctorate dissertation (2005) and the French Society of Angeology Junior Prize for the best master’s dissertation (2005). She was also honored with the Young Investigator Prize at JESFC 2017 and received an ESC Grant in 2020 to attend the Women Transforming Leadership Programme, highlighting her continued excellence in cardiology and leadership development.

Research Experience:

Dr. Stéphane Manzo-Silberman serves as the principal investigator in numerous multicenter academic clinical research studies. Her work includes leading pivotal studies such as the DOLORES registry, the DeFSSICA survey on acute heart failure management, and the First French Metaregistry on gender differences in myocardial infarction. She has also co-authored the EAPCI Women’s Survey on radiation protection in catheterization labs and chaired an EAPCI position statement on radiation protection during pregnancy for healthcare professionals. Additionally, she oversees major national projects like the WAMIF study on acute myocardial infarction in young women and the ACFA study on atrial fibrillation care pathways. Dr. Manzo-Silberman also actively directs theses and dissertations, mentoring the next generation of cardiology professionals.

Conclusion:

Dr. Stéphane Manzo-Silberman stands as a prominent figure in the field of cardiology, reflecting a deep commitment to advancing cardiovascular health and understanding. His extensive research, focused on the intricate dynamics of heart disease, particularly among diverse populations, underscores the critical importance of tailored medical approaches. Through his leadership in various studies and initiatives, Dr. Manzo-Silberman not only contributes to the scientific community but also advocates for improved patient outcomes and health equity. As he continues to explore new frontiers in cardiology, his work promises to inspire future generations of medical professionals and researchers, paving the way for innovative solutions to the challenges faced in cardiovascular care.

Top Notable Publications:

Laghlam, D., Benghanem, S., Ortuno, S., Hamzaoui, O., & Aissaoui, N. (2024). Management of cardiogenic shock: A narrative review. Annals of Intensive Care, 14(1), 45.

Sabouret, P., Barbato, E., Montalescot, G., Biondi-Zoccai, G., & Manzo-Silberman, S. (2024). Remembering our friend Jean-Philippe Collet: A giant in cardiology, a gentleman in life. Minerva Cardiology and Angiology, 72(4), 329-331.

Manzo-Silberman, S., Martin, A.-C., Boissier, F., Puymirat, E., & Delmas, C. (2024). Sex disparities in cardiogenic shock: Insights from the FRENSHOCK registry. Journal of Critical Care, 82, 154785.

Manzo-Silberman, S., Guedeney, P., Cayla, G., Montalescot, G., & Silvain, J. (2024). Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients with Chronic Coronary Syndrome. JACC: Cardiovascular Interventions, 17(12), 1413-1421.

Manzo-Silberman, S., Montalescot, G., & Lebreton, G. (2024). Has DanGer-Shock reshuffled the cards for mechanical circulatory support trials? Archives of Cardiovascular Diseases (Article in Press).

Hebbo, E., Khan, S., Manzo-Silberman, S., & Alasnag, M. (2024). The Clinical Approach to Angina in Women. Interventional Cardiology Clinics (Article in Press).

Manzo-Silberman, S., & Montalescot, G. (2023). Benefits of an observatory for myocardial infarction in women under 50: The WAMIF study. Annales de Cardiologie et d’Angeiologie, 72(6), 101691.

Manzo-Silberman, S., Chouihed, T., Ticelli, L.F., Roubille, F., & El Khoury, C. (2023). Assessment of atrial fibrillation in European emergency departments: Insights from a prospective observational multicenter study. Minerva Cardiology and Angiology, 74(4), 444-455.

Weizman, O., Tea, V., Marijon, E., Simon, T., & Danchin, N. (2023). Very long-term outcomes after acute myocardial infarction in young men and women: Insights from the FAST-MI program. Archives of Cardiovascular Diseases, 116(6-7), 324-334.

Sabouret, P., Manzo-Silberman, S., Alasnag, M., Biondi-Zoccai, G., & Bhatt, D.L. (2023). New approaches to reduce recurrent PCI: To angioplasty and beyond! European Heart Journal Open, 3(3), oead049.